Reported Jan 29, 2020 · Terminated
Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 150 mg, a) 30 count bottles (NDC: 68788-7388-3), b) 60 count…
Preferred Pharmaceuticals, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Preferred Pharmaceuticals, Inc · 1250 N Lakeview Ave Ste O · Anaheim, CA · 92807-1801
Is this the product you have?
- Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 150 mg
- a) 30 count bottles (NDC68788-7388-3)
- b) 60 count bottles (NDC68788-7388-6)
- c) 90 count bottles (NDC68788-7388-9)
- d) 100 count bottles (NDC68788-7388-1)
- Lot codes and dates
- Lot #: All lots within expiry
- Amount recalled
- 221,710 tablets
This recall covers 2 products
The agency filed one notice per product. You are reading one of them; the other one is below.
Where it was sold
Why it was recalled
CGMP Deviations: Presence of NDMA impurity detected in product.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Preferred Pharmaceuticals, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.